Equities

Bal Pharma Ltd

BALPHARMA:NSI

Bal Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)127.32
  • Today's Change-0.28 / -0.22%
  • Shares traded21.46k
  • 1 Year change+34.45%
  • Beta0.6614
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue3,3923,0422,812
OPERATING EXPENSES
Cost of revenue total1,9181,7281,675
Selling, general and admin. expenses, total604553473
Depreciation/amortization1019190
Unusual expense(income)------
Other operating expenses, total556510430
Total operating expense3,1782,8822,668
Operating income215160144
Other, net(5.71)(12)33
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes904792
Provision for income taxes162135
Net income after taxes742657
Minority interest(0.54)(0.48)(0.93)
Net income before extra. Items742656
Total extraordinary items------
Net income742656
Inc.avail. to common excl. extra. Items742656
Inc.avail. to common incl. extra. Items742656
EPS RECONCILIATION
Basic/primary weighted average shares161615
Basic/primary eps excl. extra items4.681.643.71
Basic/primary eps incl. extra items4.681.643.71
Dilution adjustment------
Diluted weighted average shares161615
Diluted eps excl. extra items4.681.643.71
Diluted eps incl. extra items4.681.643.71
COMMON STOCK DIVIDENDS
DPS - common stock primary issue1.201.001.00
Gross dividend - common stock------
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental11910185
SUPPLEMENTAL INCOME
Depreciation, supplemental707076
Total special items(0.71)(0.39)--
NORMALISED INCOME
Normalized income before taxes904792
Effect of special items on income taxes(0.13)(0.18)--
Income tax excluding impact of special items162135
Normalized income after tax742657
Normalized income avail. to common732556
Basic normalized EPS4.641.633.71
Diluted normalized EPS4.641.633.71
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.